{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:44:36Z","timestamp":1761662676697},"reference-count":58,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq Bras Endocrinol Metab"],"published-print":{"date-parts":[[2008,7]]},"abstract":"<jats:p>As primeiras descri\u00e7\u00f5es da s\u00edndrome da imunodefici\u00eancia adquirida (Aids) associavam-se \u00e0 s\u00edndrome de emaciamento, e os dist\u00farbios metab\u00f3licos \u00e0s altera\u00e7\u00f5es na composi\u00e7\u00e3o corporal. Ap\u00f3s a introdu\u00e7\u00e3o da terapia anti-retroviral altamente ativa (HAART), houve decl\u00ednio na desnutri\u00e7\u00e3o, e surge a lipodistrofia como importante dist\u00farbio metab\u00f3lico. A Aids tamb\u00e9m se caracteriza por dist\u00farbios hormonais, principalmente no eixo horm\u00f4nio de crescimento\/fator de crescimento insulina-like tipo 1 (GH\/IGF-1). O uso do GH recombinante humano (hrGH) foi inicialmente indicado na s\u00edndrome de emaciamento, a fim de aumentar a massa muscular. Embora tamb\u00e9m n\u00e3o existam d\u00favidas quanto aos efeitos do hrGH na lipodistrofia, a diminui\u00e7\u00e3o na sensibilidade \u00e0 insulina limita o seu uso, o qual ainda n\u00e3o est\u00e1 oficialmente aprovado. A diversidade nos esquemas de tratamento \u00e9 outro limitante do uso dessa medica\u00e7\u00e3o em pacientes com Aids. Esta revis\u00e3o apresenta os principais dist\u00farbios end\u00f3crino-metab\u00f3licos associados \u00e0 Aids e ao uso do hrGH nessas condi\u00e7\u00f5es.<\/jats:p>","DOI":"10.1590\/s0004-27302008000500014","type":"journal-article","created":{"date-parts":[[2008,9,29]],"date-time":"2008-09-29T14:04:10Z","timestamp":1222697050000},"page":"818-832","source":"Crossref","is-referenced-by-count":6,"title":["O papel do horm\u00f4nio de crescimento no tratamento dos dist\u00farbios end\u00f3crino-metab\u00f3licos do paciente com a s\u00edndrome da imunodefici\u00eancia adquirida (Aids)"],"prefix":"10.1590","volume":"52","author":[{"given":"Angela Maria","family":"Spinola-Castro","sequence":"first","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana A.","family":"Siviero-Miachon","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Tadeu Nolasco da","family":"Silva","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Guerra-Junior","sequence":"additional","affiliation":[{"name":"Unicamp, Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Aids Epidemic Update","year":"2007"},{"issue":"1","key":"ref2","article-title":"Programa Nacional de DST e Aids","volume":"IV","year":"2007","journal-title":"Boletim Epidemiol\u00f3gico Aids-DST"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00006454-200301000-00018","article-title":"Metabolic complications of antiretroviral therapy in children","volume":"22","author":"Leonard EG","year":"2003","journal-title":"Pediatr Infect Dis J."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000185026","article-title":"Use of human recombinant growth hormone and human recombinant insulin-like growth factor-I in patients with human immunodeficiency virus infection","volume":"46","author":"Hirschfeld S","year":"1996","journal-title":"Horm Res."},{"key":"ref5","first-page":"956","article-title":"Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection","volume":"77","author":"Mulligan K","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00042560-199909010-00006","article-title":"Insulin-like growth factor system in patients with HIV infection: effect of exogenous growth hormone administration","volume":"22","author":"Mynarcik DC","year":"1999","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2265.2005.02331.x","article-title":"Growth hormone improves protein catabolism and growth in prepubertal children with HIV infection","volume":"63","author":"Hardin DS","year":"2005","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/j.clinthera.2007.11.004","article-title":"Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment","volume":"29","author":"Gelato M","year":"2007","journal-title":"Clin Ther."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1210\/jc.2004-2431","article-title":"Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents","volume":"90","author":"Vigan\u00f2 A","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.qai.0000243108.26136.66","article-title":"Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum","volume":"43","author":"Kotler DP","year":"2006","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ncpendmet0587","article-title":"Therapy insight: body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy","volume":"3","author":"Falutz J","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"ref12","first-page":"844","article-title":"Growth hormone resurrects adult human thymus during HIV-1 infection","volume":"3","author":"Tesselaar K","year":"2008","journal-title":"J Clin Invest."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1210\/jcem.86.8.7785","article-title":"The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation","volume":"86","author":"Lo JC","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe","volume":"18","year":"2004","journal-title":"Aids","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref15","series-title":"Programa Nacional de DST e Aids Bras\u00edlia (PN DST-Aids)","volume":"60","year":"2004"},{"key":"ref16","first-page":"2014","year":"1999"},{"key":"ref17","first-page":"1033","article-title":"Pediatric Aids Clinical Trials Group Protocol 152 Study Team: Growth, survival and viral load in childhood HIV infection","volume":"22","author":"Chantry C","year":"2003","journal-title":"Pediatr Infect Dis J."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1097\/01.qai.0000144384.55091.0f","article-title":"The HIV wasting collaborative consensus committee: Collaborative recommendations. The approach to diagnosis and treatment of hiv wasting","volume":"37","author":"Wanke C","year":"2004","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jac\/dkm499","article-title":"Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act","volume":"61","author":"Burgoyne RW","year":"2008","journal-title":"J Antimicrob Chemother","ISSN":"http:\/\/id.crossref.org\/issn\/0305-7453","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00006454-200103000-00020","article-title":"Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children","volume":"20","author":"Dreimane D","year":"2001","journal-title":"Pediatr Infect Dis J."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1542\/peds.109.2.e25","article-title":"Treatment with highly active antiretroviral therapy in human immunodeficiency virus type-1-infected children is associated with a sustained effect on growth","volume":"109","author":"Verweel G","year":"2000","journal-title":"Pediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0140-6736(05)67022-5","article-title":"Swiss HIV cohort study. Long-term effectiveness of potent antiretroviral therapy in preventing Aids and death: a prospective cohort study","volume":"366","author":"Sterne JA","year":"2005","journal-title":"Lancet."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/526524","article-title":"Pediatric Aids Clinical Trials Group 219\/219C Study Team: Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study","volume":"46","author":"Patel K","year":"2008","journal-title":"Clin Infect Dis."},{"key":"ref24","series-title":"Cachexia and wasting: a modern approach","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-88-470-0552-5_40","volume-title":"HIV infection-related cachexia and lipodystrophy","author":"Scevola D","year":"2006"},{"key":"ref25","first-page":"1","article-title":"1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age","volume":"43","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/500398","article-title":"Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort","volume":"42","author":"Mangili A","year":"2006","journal-title":"Clin Infect Dis."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.idc.2005.05.006","article-title":"Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival","volume":"19","author":"Leonard EG","year":"2005","journal-title":"Infect Dis Clin North Am."},{"key":"ref28","first-page":"229","article-title":"SPNS\/GEAM\/SENBA\/SENPE\/AEDN\/SEDCA\/GESIDA: Recommendations from SPNS\/GEAM\/SENBA\/SENPE\/AEDN\/SEDCA\/GESIDA on nutrition in the HIV-infected patient","volume":"22","author":"Polo R","year":"2007","journal-title":"Nutr Hosp."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.inf.0000247131.76584.af","article-title":"Endocrine abnormalities and impaired growth in human immunodeficiency virus-infected children","volume":"26","author":"Chantry CJ","year":"2007","journal-title":"Pediatr Infect Dis J."},{"key":"ref30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1590\/S0004-27302005000600004","article-title":"Altera\u00e7\u00f5es metab\u00f3licas da s\u00edndrome lipodistr\u00f3fica do HIV","volume":"49","author":"Valente AMM","year":"2005","journal-title":"Arq Bras Endocrinol Metab."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc T","year":"1999","journal-title":"Aids","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1468-1293.2007.00534.x","article-title":"EACS Executive Committee: European Aids Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV","volume":"9","author":"Lundgren JD","year":"2008","journal-title":"HIV Medicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0022-3476(05)80685-7","article-title":"Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome","volume":"117","author":"Laue L","year":"1990","journal-title":"J Pediatr."},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1651-2227.1994.tb12977.x","article-title":"Growth impairment, IGF I hyposecretion and thyroid dysfunction in children with perinatal HIV-1 infection","volume":"83","author":"Matarazzo P","year":"1994","journal-title":"Acta Paediatr."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/JPEM.2004.17.1.33","article-title":"Endocrine function in Thai children infected with human immunodeficiency virus","volume":"17","author":"Panamonta O","year":"2004","journal-title":"J Pediatr Endocrinol Metab."},{"key":"ref36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/088922202753519106","article-title":"Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 response to growth hormone is impaired in HIV-infected children","volume":"18","author":"Rondanelli M","year":"2002","journal-title":"Aids Res Hum Retroviruses","ISSN":"http:\/\/id.crossref.org\/issn\/0889-2229","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0196-9781(01)00341-2","article-title":"Decreased neuropeptide Y (NPY) expression in the infundibular nucleus of patients with nonthyroidal illness","volume":"22","author":"Fliers E","year":"2001","journal-title":"Peptides","ISSN":"http:\/\/id.crossref.org\/issn\/0079-0753","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000441-200102000-00005","article-title":"Adrenal insufficiency in HIV infection: a review and recommendations","volume":"321","author":"Eledrisi MS","year":"2001","journal-title":"Am J Med Sci."},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0140-6736(92)91592-V","article-title":"Prognostic factors and survival in children with perinatal HIV infection","volume":"339","author":"Tovo PA","year":"1992","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archpedi.156.5.497","article-title":"Growth in human immunodeficiency virus-infected children receiving ritonavir-containing antiretroviral therapy","volume":"156","author":"Nachman SA","year":"2002","journal-title":"Arch Pediatr Adolesc Med."},{"key":"ref41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cccn.2005.05.001","article-title":"Monitoring insulin-like growth factors in HIV infection and aids","volume":"361","author":"Congote LF","year":"2005","journal-title":"Clin Chim Acta","ISSN":"http:\/\/id.crossref.org\/issn\/0009-8981","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00019616-200105000-00005","article-title":"Regulation of the growth hormone\/insulin-like growth factor-I axis in HIV disease","volume":"11","author":"Meininger G","year":"2001","journal-title":"Endocrinologist","ISSN":"http:\/\/id.crossref.org\/issn\/1051-2144","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.1996.705526.x","article-title":"Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system","volume":"44","author":"Frost RA","year":"1996","journal-title":"Clin Endocrinol (Oxf)","ISSN":"http:\/\/id.crossref.org\/issn\/0300-0664","issn-type":"print"},{"key":"ref44","first-page":"4028","article-title":"Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome","volume":"81","author":"Heijligenberg R","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"key":"ref45","first-page":"1243","article-title":"Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone and prolactin during HIV infection","volume":"13","author":"Rondanelli M","year":"1997","journal-title":"Aids","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref46","article-title":"GH\/GHRH axis in HIV lipodystrophy","author":"Stanley TL","year":"2008","journal-title":"Pituitary","ISSN":"http:\/\/id.crossref.org\/issn\/1386-341X","issn-type":"print"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00002030-200307040-00003","article-title":"Impaired growth hormone secretion correlates with visceral adiposity in highly active antiretroviral treated HIV-infected adolescents","volume":"17","author":"Vigan\u00f2 A","year":"2003","journal-title":"Aids","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00006454-200301000-00017","article-title":"Endocrinology and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors","volume":"22","author":"Van Rossum AMC","year":"2003","journal-title":"Pediatric Infect Dis J."},{"key":"ref49","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting: A randomized, placebo-controlled trial","volume":"125","author":"Schambelan M","year":"1996","journal-title":"Serostim Study Group. Ann Intern Med."},{"key":"ref50","first-page":"245","article-title":"Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in Aids and Aids-related complex","volume":"6","author":"Krentz AJ","year":"1993","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1172\/JCI119747","article-title":"Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease","volume":"100","author":"McNurlan MA","year":"1997","journal-title":"J Clin Invest."},{"key":"ref52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.7326\/0003-4819-125-11-199612010-00001","article-title":"Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in Aids-associated wasting: a randomized, double-blind, placebocontrolled trial","volume":"125","author":"Waters D","year":"1996","journal-title":"Ann Intern Med."},{"key":"ref53","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1210\/jc.2004-0451","article-title":"Growth hormone treatment improves peripheral muscle oxygen extraction-utilization during exercise in patients with human immunodeficiency virus-associated wasting: A randomized controlled trial","volume":"89","author":"Esposito JG","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00126334-200404010-00006","article-title":"Serono 9037 Study Team: Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy","volume":"35","author":"Moyle GJ","year":"2004","journal-title":"J Acquir Immune Defic Syndr."},{"key":"ref55","doi-asserted-by":"crossref","first-page":"4474","DOI":"10.1210\/jc.2005-0275","article-title":"A randomized, placebocontrolled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment","volume":"90","author":"Storer TW","year":"2005","journal-title":"J Clin Endocrinol Metab","ISSN":"http:\/\/id.crossref.org\/issn\/0021-972X","issn-type":"print"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-199910220-00013","article-title":"Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV","volume":"13","author":"Wanke C","year":"1999","journal-title":"Aids","ISSN":"http:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0065-3101(24)00029-X","article-title":"Advances in the recognition and treatment of endocrine complications in children with chronic illness","volume":"46","author":"Zeitler PS","year":"1999","journal-title":"Adv Pediatr."},{"key":"ref58","first-page":"1085","article-title":"Growth hormone enhances thymic function in HIV-infected adults","volume":"118","author":"Napolitano LA","year":"2008","journal-title":"J Clin Invest."}],"container-title":["Arquivos Brasileiros de Endocrinologia &amp; Metabologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abem\/v52n5\/14.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T03:40:33Z","timestamp":1709264433000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-27302008000500014&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0004-27302008000500014"],"URL":"https:\/\/doi.org\/10.1590\/s0004-27302008000500014","relation":{},"ISSN":["0004-2730"],"issn-type":[{"value":"0004-2730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}